Abstract:Objective To elucidate the role of METTL14-mediated m6A methylation of ACSL4 in ferroptosis and senescence of nucleus pulposus cells.Methods Human nucleus pulposus cells were utilized to establish a tert-butyl hydroperoxide-induced cell model. Stable cell lines were generated with either overexpression or knockdown of METTL14. Intracellular levels of ferrous ions, MDA, GSH, and GPX4 were quantified using spectrophotometry, while ROS and mitochondrial membrane potential were measured via flow cytometry. Cell senescence was evaluated through β-galactosidase staining. The methylated RNA immunoprecipitation (MeRIP) and quantitative real-time polymerase chain reaction (qRT-PCR), as well as RNA stability experiments, were performed to investigate the regulatory effects of METTL14 on ACSL4 expression.Results METTL14 overexpression in nucleus pulposus cells caused significant iron overload (P < 0.05), increased ROS levels (P < 0.05), elevated MDA levels (P < 0.05), a significant decrease in GSH and GPX 4 levels (P < 0.05), and a reduction in the mitochondrial membrane potential (P < 0.05), thus promoting cellular senescence. Using MeRIP-qRT-PCR and RNA stability assays, we found that METTL14 regulated the expression of ACSL4 and affected its mRNA stability (P < 0.05). The rescue experiment further confirmed that METTL14 promoted nucleus pulposus cell senescence by regulating ACSL 4 (P < 0.05).Conclusions This study unveils the role of METTL14 in promoting ferroptosis and senescence of nucleus pulposus cells via mediating m6A methylation of ACSL4, offering a novel perspective and potential therapeutic target for understanding the pathogenesis of diseases involving nucleus pulposus cells.